Study
MAY, BLIND
This open prospective randomized blind clinical trial was performed from January to May 2022 at the tertiary care academic teaching hospital after receiving ethics committee approval (SBNK-YJ-2021-030-01). Written informed consent was obtained from the legal guardians of all the pediatric patients. This study was registered before participants were recruited at the Chinese Clinical Trial Registry (